Clinical Trial Update: A Study of LY4152199 in Participants With Previously Treated B-cell Cancers (BAF_FRontier-1 ) [Phase 1]

View source ↗

Summary

A Phase 1 study of LY4152199 in previously treated B-cell cancers is listed, with the trial currently NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Lymphoma
• Diffuse Large B-cell Lymphoma
• Follicular Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• LY4152199

Snippet

Sponsor: Eli Lilly and Company | Conditions: Lymphoma, Non-Hodgkin, B-cell Lymphoma | Phase 1 | Status: NOT_YET_RECRUITING